RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation

NCT03948529 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped inclusions difficulties.

Conditions

Leukemia
Graft Failure

Interventions

DRUG: eltrombopag

Sponsor

University Hospital, Lille